Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
UPDATE: Cowen Downgrades Orchard Therapeutics (ORTX) to Market Perform
-
Orchard Therapeutics to Present at Multiple Investor Conferences in March 2022
-
Orchard Therapeutics to Present at Multiple Investor Conferences in March 2022
-
Orchard Therapeutics to Present at Multiple Investor Conferences in March 2021
-
Orchard Therapeutics to Present at Multiple Investor Conferences in March 2021
-
Orchard Therapeutics Plc (ORTX) Reports $150M Strategic PIPE Financing from 24.12M Share Sale at $6.22/Sh
-
Orchard Therapeutics Announces $150 Million Strategic Financing
-
Orchard Therapeutics Announces $150 Million Strategic Financing
-
Orchard Therapeutics to Present at Investor Conferences in March
-
Orchard Therapeutics to Present at Investor Conferences in March
-
Cowen Assumes Orchard Therapeutics (ORTX) at Outperform
-
Orchard Therapeutics Plc (ORTX) Prices 9M ADS Offering for Gross Proceeds of Approx. $128M
-
Orchard Therapeutics Announced Pricing of Public Offering
-
Orchard Therapeutics Announced Pricing of Public Offering
-
Orchard Therapeutics Plc (ORTX) Launches 9M Proposed Public Offering of ADSs
-
Orchard Therapeutics Launches Proposed Public Offering
-
Orchard Therapeutics Launches Proposed Public Offering
-
Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019
-
Orchard Therapeutics to Present at the Cowen 39th Annual Health Care Conference on March 11, 2019
-
Cowen Starts Orchard Therapeutics (ORTX) at Outperform
-
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option
-
Orchard Therapeutics Plc (ORTX) Prices 14.29M ADS IPO at $14/ADS
-
Orchard Therapeutics Announces Pricing of Initial Public Offering
